HPV Vaccination
17
2
5
5
Key Insights
Highlights
Success Rate
71% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
11.8%
2 terminated out of 17 trials
71.4%
-15.1% vs benchmark
12%
2 trials in Phase 3/4
40%
2 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (17)
A Trial to Establish Non-inferiority of Immunogenicity of a Single-dose of CERVAVAC® Quadrivalent HPV Vaccine Compared to the Gardasil® Quadrivalent Vaccine Among Girls and Boys Aged 9 to 14 Years and in Girls/Women Aged 15 to 20 Years in Zambia
PREVENT Pilot HPV - Related Cancers Trial
Culturally Targeted Health Communication and Receptivity to the Human Papillomavirus Vaccine Among Parents in Flint, MI
PREVENT HPV -Related Cancers Trial
Trial of a Social Marketing Campaign to Increase HPV Vaccination Among Mexican American Children
OPERATION WIPE OUT: Multi-Channel Communication Campaign to Promote HPV Vaccination in Chambers County, Alabama
Parents' HPV Stories
Empowering Vietnamese Americans
Study for Prevention of Cervical Cancer in Spain
Integrated HPV Vaccination and Adolescent Health in Ivory Coast
PREVENT HPV-Related Cancers - BootCamp Translation
Impact of Catch-up HPV Vaccination
Effectiveness of the Q-HPV Vaccine 9-years Post Vaccination Among HIV Positive Adolescents
Evaluation of the Implementation and Effectiveness of IPP-HPV
Impact of HPV Vaccination to Catch up in the Emergence of Lesions of the Cervix
Health Belief Model-based Education and Motivational Interview Regarding the HPV Vaccination Decision
Increasing HPV Vaccination Rates Via Educational Interventions in Schools Located Within Cedars-Sinai Catchment Areas